Stockreport

Precision Therapeutics Gains Extension for Nasdaq Compliance

PRECISION THERAPEUTICS INC COMMON  (AIPT) 
US:NASDAQ Investor Relations: investors.skylinemedical.com/investor-relations
PDF MINNEAPOLIS, May 17, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intel [Read more]